Acumed Beats Stryker in Patent Infringement Case

January 7, 2009
A federal appeals court has upheld a permanent injunction against Stryker, banning the company from selling its T2 proximal humeral nail (PHN) used to treat fractures of the humerus. The U.S. Court of Appeals for the Federal Circuit ruled in favor of Acumed, which holds the patent for the PHN. The ruling backed a previous decision by the U.S. District Court for the District of Oregon, which concluded that Acumed would be irreparably harmed by the loss of income from the screws and public health would not be impaired by the decision.
Devices & Diagnostics Letter